We are analyzing https://link.springer.com/article/10.1007/bf00868525.

Title:
Effects of long-term treatment in Wilson's disease withd-penicillamine and zinc sulphate | Journal of Neurology
Description:
Journal of Neurology - The results of treatment withd-penicillamine (d-P) or zinc sulphate (Zn) in 67 newly diagnosed cases of Wilson
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Science
Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

disease, wilsons, google, scholar, therapy, pubmed, zinc, patients, article, neurol, med, treatment, penicillamine, czlonkowska, walshe, content, cases, access, privacy, cookies, journal, longterm, sulphate, rodo, degeneration, van, publish, search, neurology, effects, initial, brewer, arch, hepatolenticular, acta, data, information, log, research, withdpenicillamine, anna, gajda, hepatic, neurological, institution, agent, open, chelation, discover, management,

Topics {✒️}

month download article/chapter privacy choices/manage cookies related subjects long-term care full article pdf long-term treatment continuous zinc therapy oral zinc therapy van der wiel interrupting penicillamine therapy european economic area march 1996 volume 243 triethylene tetramine dihydrochloride initial penicillamine therapy conditions privacy policy check access instant access zinc sulphate article czlonkowska treatment withd-penicillamine longterm treatment withd walshe jm hepato-cerebral degeneration accepting optional cookies d-penicillamine disease withd-penicillamine initial penicillamine chelation journal finder publish received zn deteriorated fatal deterioration wilson' main content log zinc therapy article journal manchester university press patients discontinued zn cumings jn article log oral therapy initial therapy article cite privacy policy personal data books a van hattum combination therapy penicillamine treatment optional cookies manage preferences d penicillamine nephropathy

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Effects of long-term treatment in Wilson's disease withd-penicillamine and zinc sulphate
         description:The results of treatment withd-penicillamine (d-P) or zinc sulphate (Zn) in 67 newly diagnosed cases of Wilson's disease have been compared. All patients (7 with hepatic, 1 with psychiatric and 59 with neurological or preclinical forms) were fully compliant. During 12 years of observation, 34 patients receivedd-P and 33 Zn as the primary treatment. Fifteen patients (44%) discontinuedd-P, in 10 cases owing to side effects. Four (12%) patients discontinued Zn, in 2 cases because of side-effects. One patient who received Zn deteriorated during the first few months after the initiation of therapy. The effectiveness of longterm treatment withd-P and Zn was similar in those patients who were able to continue the initial therapy. Zn was tolerated better thand-P; we suggest, therefore, that it may be recommended as an initial therapy for patients in the preclinical stage of Wilson's disease or with neurological presentation of the disease. More observation is needed for patients with the hepatic and psychiatric forms of the disease.
         datePublished:
         dateModified:
         pageStart:269
         pageEnd:273
         sameAs:https://doi.org/10.1007/BF00868525
         keywords:
            Wilson's disease
             d-penicillamine
            Zinc sulphate
            Neurology
            Neurosciences
            Neuroradiology
         image:
         isPartOf:
            name:Journal of Neurology
            issn:
               1432-1459
               0340-5354
            volumeNumber:243
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Anna Czlonkowska
               affiliation:
                     name:Institute of Psychiatry and Neurology
                     address:
                        name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jolanta Gajda
               affiliation:
                     name:Institute of Psychiatry and Neurology
                     address:
                        name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Maria Rodo
               affiliation:
                     name:Institute of Psychiatry and Neurology
                     address:
                        name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Effects of long-term treatment in Wilson's disease withd-penicillamine and zinc sulphate
      description:The results of treatment withd-penicillamine (d-P) or zinc sulphate (Zn) in 67 newly diagnosed cases of Wilson's disease have been compared. All patients (7 with hepatic, 1 with psychiatric and 59 with neurological or preclinical forms) were fully compliant. During 12 years of observation, 34 patients receivedd-P and 33 Zn as the primary treatment. Fifteen patients (44%) discontinuedd-P, in 10 cases owing to side effects. Four (12%) patients discontinued Zn, in 2 cases because of side-effects. One patient who received Zn deteriorated during the first few months after the initiation of therapy. The effectiveness of longterm treatment withd-P and Zn was similar in those patients who were able to continue the initial therapy. Zn was tolerated better thand-P; we suggest, therefore, that it may be recommended as an initial therapy for patients in the preclinical stage of Wilson's disease or with neurological presentation of the disease. More observation is needed for patients with the hepatic and psychiatric forms of the disease.
      datePublished:
      dateModified:
      pageStart:269
      pageEnd:273
      sameAs:https://doi.org/10.1007/BF00868525
      keywords:
         Wilson's disease
          d-penicillamine
         Zinc sulphate
         Neurology
         Neurosciences
         Neuroradiology
      image:
      isPartOf:
         name:Journal of Neurology
         issn:
            1432-1459
            0340-5354
         volumeNumber:243
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Anna Czlonkowska
            affiliation:
                  name:Institute of Psychiatry and Neurology
                  address:
                     name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jolanta Gajda
            affiliation:
                  name:Institute of Psychiatry and Neurology
                  address:
                     name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Maria Rodo
            affiliation:
                  name:Institute of Psychiatry and Neurology
                  address:
                     name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neurology
      issn:
         1432-1459
         0340-5354
      volumeNumber:243
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Institute of Psychiatry and Neurology
      address:
         name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
         type:PostalAddress
      name:Institute of Psychiatry and Neurology
      address:
         name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
         type:PostalAddress
      name:Institute of Psychiatry and Neurology
      address:
         name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Anna Czlonkowska
      affiliation:
            name:Institute of Psychiatry and Neurology
            address:
               name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
               type:PostalAddress
            type:Organization
      name:Jolanta Gajda
      affiliation:
            name:Institute of Psychiatry and Neurology
            address:
               name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
               type:PostalAddress
            type:Organization
      name:Maria Rodo
      affiliation:
            name:Institute of Psychiatry and Neurology
            address:
               name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
               type:PostalAddress
            type:Organization
PostalAddress:
      name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
      name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
      name:2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(70)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.13s.

LINK . SPRINGER . COM {}